Performance of the American Heart Association PREVENT Cardiovascular Risk Equations in Older Adults

医学 阿司匹林 队列 动脉粥样硬化性心血管疾病 弗雷明翰风险评分 比例危险模型 前瞻性队列研究 队列研究 内科学 随机对照试验 人口学 疾病 社会学
作者
Michelle A. Fravel,Michael E. Ernst,Robyn L. Woods,Suzanne G. Orchard,Shiva Ganjali,James B. Wetmore,Christopher M. Reid,Joanne Ryan,Kevan R. Polkinghorne,Rory Wolfe,Mark Nelson,Sophia Zoungas,Zhen Zhou
出处
期刊:Circulation-cardiovascular Quality and Outcomes [Lippincott Williams & Wilkins]
标识
DOI:10.1161/circoutcomes.124.011719
摘要

BACKGROUND: The ability of the American Heart Association Predicting Risk of Cardiovascular Disease Events (PREVENT) calculator to accurately assign 10-year atherosclerotic cardiovascular disease (ASCVD) risk in older individuals, including those aged ≥80 years, is unknown. This study compares PREVENT with the 2013 Pooled Cohort Equation (PCE) calculator for predicting 10-year ASCVD risk in a large cohort of older adults. METHODS: This was a prospective cohort study of adults without CVD from Australia and the United States aged ≥70 years (≥65 years, if US minorities). They were enrolled from 2010 to 2014 in the ASPREE trial (Aspirin in Reducing Events in the Elderly), a 5-year randomized trial of low-dose aspirin in community-dwelling older adults with posttrial observational follow-up extending to 2022. ASCVD events were adjudicated by expert panels. The discriminative ability of the 2 risk calculators was assessed by Harell C statistic following Cox regression in the 65- to 79-year age group and >80-year age group, separately. For calibration, predicted event numbers were calculated using PREVENT and PCE, scaled for the actual length of follow-up, and compared with the number of observed events in-trial and during extended follow-up. RESULTS: Among the 15 510 participants aged 65 to 79 years (median age, 73.2 years; 56.1% women), 1084 ASCVD events occurred (median follow-up, 8.3 years); PCE predicted 3102 events while PREVENT predicted 1290 events. For the 2787 participants ≥80 years (median age, 82.6 years; 59.2% women), 355 ASCVD events occurred (median follow-up, 7.4 years); PCE predicted 1067 events while PREVENT predicted 350 events. PREVENT showed superior discriminative performance compared with PCE (PREVENT versus PCE, C statistic, 0.793 versus 0.740; P <0.001 in participants aged 65 –79 years; 0.854 versus 0.799; P <0.001 in those aged ≥80 years). CONCLUSIONS: The PREVENT risk calculator is superior to the PCE calculator in predicting ASCVD events in older adults from the United States and Australia, including those aged ≥80 years. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01038583. URL: https://www.isrctn.com ; Unique identifier: ISRCTN83772183.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
天真的idiot完成签到 ,获得积分10
2秒前
学术laji发布了新的文献求助10
2秒前
支付宝发布了新的文献求助10
3秒前
3秒前
奋斗奋斗再奋斗完成签到,获得积分10
5秒前
笑笑完成签到 ,获得积分10
7秒前
清修完成签到,获得积分10
8秒前
xingxing完成签到 ,获得积分10
9秒前
10秒前
白菜完成签到,获得积分10
12秒前
支付宝完成签到,获得积分10
13秒前
mm完成签到 ,获得积分10
13秒前
研友_n0kjPL完成签到,获得积分0
14秒前
Samia发布了新的文献求助10
16秒前
甜蜜鹭洋完成签到 ,获得积分10
16秒前
科研通AI5应助手术刀采纳,获得10
18秒前
打地鼠工人完成签到,获得积分10
20秒前
zhilianghui0807完成签到 ,获得积分10
21秒前
laohu完成签到,获得积分10
22秒前
五十完成签到,获得积分10
24秒前
25秒前
小灰灰完成签到 ,获得积分10
28秒前
蓝华完成签到 ,获得积分10
29秒前
手术刀发布了新的文献求助10
31秒前
mengmenglv完成签到 ,获得积分0
31秒前
有我ID随机吗完成签到,获得积分10
33秒前
忞航完成签到 ,获得积分10
36秒前
呼呼呼完成签到,获得积分10
36秒前
Yiling完成签到,获得积分10
38秒前
学术laji完成签到 ,获得积分10
42秒前
大椒完成签到 ,获得积分10
47秒前
木木完成签到 ,获得积分10
49秒前
卜哥完成签到 ,获得积分10
50秒前
鲁滨逊完成签到 ,获得积分10
53秒前
Lamis完成签到 ,获得积分10
54秒前
C_Li完成签到,获得积分10
55秒前
感性的俊驰完成签到 ,获得积分10
58秒前
东少完成签到,获得积分10
59秒前
sweet雪儿妞妞完成签到 ,获得积分10
59秒前
打工仔完成签到 ,获得积分10
1分钟前
高分求助中
(禁止应助)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Diagnostic Imaging: Pediatric Neuroradiology 2000
Semantics for Latin: An Introduction 1099
Biology of the Indian Stingless Bee: Tetragonula iridipennis Smith 1000
Robot-supported joining of reinforcement textiles with one-sided sewing heads 720
Battery Management Systems, Volume lll: Physics-Based Methods 550
Corpus Linguistics for Language Learning Research 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4136857
求助须知:如何正确求助?哪些是违规求助? 3673612
关于积分的说明 11611685
捐赠科研通 3368407
什么是DOI,文献DOI怎么找? 1850484
邀请新用户注册赠送积分活动 913835
科研通“疑难数据库(出版商)”最低求助积分说明 828956